{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:30:23Z","timestamp":1794238223254,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2016R1D1A1A02937044"],"award-info":[{"award-number":["2016R1D1A1A02937044"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1842-x","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T09:04:29Z","timestamp":1550221469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Eun Hye","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"issue":"3","key":"1842_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2(3):137\u201352.","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"1842_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MD.0b013e3181dde28d","volume":"89","author":"M Hudson","year":"2010","unstructured":"Hudson M, Fritzler MJ, Baron M, Canadian Scleroderma Research G. Systemic sclerosis: establishing diagnostic criteria. Medicine (Baltimore). 2010;89(3):159\u201365.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1842_CR3","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"8","key":"1842_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.24676","volume":"61","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research G. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum. 2009;61(8):1112\u201320.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1842_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3899\/jrheum.080281","volume":"36","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma Research G. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol. 2009;36(4):768\u201372.","journal-title":"J Rheumatol"},{"issue":"1","key":"1842_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10067-004-0970-z","volume":"24","author":"E Danieli","year":"2005","unstructured":"Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, Franceschini F, Cattaneo R. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol. 2005;24(1):48\u201354.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1842_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10067-014-2525-2","volume":"33","author":"PT Chan","year":"2014","unstructured":"Chan PT, Mok CC, Chan KL, Ho LY. Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study. Clin Rheumatol. 2014;33(5):659\u201366.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1842_CR8","first-page":"1117","volume":"33","author":"SR Johnson","year":"2006","unstructured":"Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol. 2006;33(6):1117\u201322.","journal-title":"J Rheumatol"},{"issue":"12","key":"1842_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189840","volume":"12","author":"J Greenfield","year":"2017","unstructured":"Greenfield J, Hudson M, Vinet E, Fortin PR, Bykerk V, Pineau CA, Wang M, Bernatsky S, Baron M, Canadian Scleroderma Research G, et al. A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs). PLoS One. 2017;12(12):e0189840.","journal-title":"PLoS One"},{"issue":"11","key":"1842_CR10","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1842_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1842_CR12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1842_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1842_CR14","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1842_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1842_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1842_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.anr.2013.03.001","volume":"7","author":"SH Kim","year":"2013","unstructured":"Kim SH, Jo MW, Lee SI. Psychometric properties of the Korean short form-36 health survey version 2 for assessing the general population. Asian Nurs Res (Korean Soc Nurs Sci). 2013;7(2):61\u20136.","journal-title":"Asian Nurs Res (Korean Soc Nurs Sci)"},{"issue":"6","key":"1842_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"3","key":"1842_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1620\/tjem.203.189","volume":"203","author":"CW Han","year":"2004","unstructured":"Han CW, Lee EJ, Iwaya T, Kataoka H, Kohzuki M. Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med. 2004;203(3):189\u201394.","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"1842_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337\u201343.","journal-title":"Ann Med"},{"issue":"8","key":"1842_CR21","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1524-4733.2009.00579.x","volume":"12","author":"YK Lee","year":"2009","unstructured":"Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health. 2009;12(8):1187\u201393.","journal-title":"Value Health"},{"issue":"2","key":"1842_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1524-4733.2008.00428.x","volume":"12","author":"R Ara","year":"2009","unstructured":"Ara R, Brazier J. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health. 2009;12(2):346\u201353.","journal-title":"Value Health"},{"issue":"3","key":"1842_CR23","first-page":"579","volume":"20","author":"DM Heijde van der","year":"1993","unstructured":"van der Heijde DM, van \u2019t Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993;20(3):579\u201381.","journal-title":"J Rheumatol"},{"issue":"2","key":"1842_CR24","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"6","key":"1842_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, et al. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2010;69(6):1103\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1842_CR26","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.10486","volume":"46","author":"PA Merkel","year":"2002","unstructured":"Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon. Arthritis Rheum. 2002;46(9):2410\u201320.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1842_CR27","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/art.1780401110","volume":"40","author":"VD Steen","year":"1997","unstructured":"Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40(11):1984\u201391.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1842_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/art.21084","volume":"53","author":"SR Johnson","year":"2005","unstructured":"Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties. Arthritis Rheum. 2005;53(2):256\u201362.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 11","key":"1842_CR29","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1002\/acr.20598","volume":"63","author":"J Pope","year":"2011","unstructured":"Pope J. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler\u2019s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud\u2019s Condition Score (RCS). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S98\u2013111.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1842_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","volume":"24","author":"C Georges","year":"2005","unstructured":"Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, Marjanovic Z, Heneggar C, Papo T, Crickx B, et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol. 2005;24(1):3\u201310.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1842_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012;64(5):640\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"1842_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/acr.23109","volume":"69","author":"A Polachek","year":"2017","unstructured":"Polachek A, Gladman DD, Su J, Urowitz MB. Defining low disease activity in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2017;69(7):997\u20131003.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"1842_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, et al. Defining disease activity states and clinically meaningful improvement in primary Sjogren\u2019s syndrome with EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2016;75(2):382\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1842_CR34","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"9285","key":"1842_CR35","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903\u201311.","journal-title":"Lancet"},{"issue":"4","key":"1842_CR36","first-page":"551","volume":"35","author":"GMC Paglia La","year":"2017","unstructured":"La Paglia GMC, Leone MC, Lepri G, Vagelli R, Valentini E, Alunno A, Tani C. One year in review 2017: systemic lupus erythematosus. Clin Exp Rheumatol. 2017;35(4):551\u201361.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1842_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/13548506.2010.540250","volume":"16","author":"K Amin","year":"2011","unstructured":"Amin K, Clarke A, Sivakumar B, Puri A, Fox Z, Brough V, Denton CP, Peter EM, Butler P. The psychological impact of facial changes in scleroderma. Psychol Health Med. 2011;16(3):304\u201312.","journal-title":"Psychol Health Med"},{"issue":"2","key":"1842_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1037\/0278-6133.22.2.130","volume":"22","author":"LM Benrud-Larson","year":"2003","unstructured":"Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, Haythornthwaite JA. Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function. Health Psychol. 2003;22(2):130\u20139.","journal-title":"Health Psychol"},{"issue":"2","key":"1842_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/RHU.0000000000000428","volume":"23","author":"ST Faezi","year":"2017","unstructured":"Faezi ST, Paragomi P, Shahali A, Akhlaghkhah M, Akbarian M, Akhlaghi M, Kheirandish M, Gharibdoost F. Prevalence and severity of depression and anxiety in patients with systemic sclerosis: an epidemiologic survey and investigation of clinical correlates. J Clin Rheumatol. 2017;23(2):80\u20136.","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"1842_CR40","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","volume":"14","author":"C Bruni","year":"2015","unstructured":"Bruni C, Raja J, Denton CP, Matucci-Cerinic M. The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmun Rev. 2015;14(12):1111\u20135.","journal-title":"Autoimmun Rev"},{"key":"1842_CR41","doi-asserted-by":"publisher","unstructured":"Fernandez-Martinez G, Zamora-Legoff V, Hernandez Molina G. Oral health-related quality of life in primary Sjogren\u2019s syndrome. Reumatol Clin. 2018. \n                    https:\/\/doi.org\/10.1016\/j.reuma.2018.04.001\n                    \n                  .","DOI":"10.1016\/j.reuma.2018.04.001"},{"issue":"50","key":"1842_CR42","doi-asserted-by":"publisher","first-page":"e9208","DOI":"10.1097\/MD.0000000000009208","volume":"96","author":"Z Liu","year":"2017","unstructured":"Liu Z, Dong Z, Liang X, Liu J, Xuan L, Wang J, Zhang G, Hao W. Health-related quality of life and psychological status of women with primary Sjogren\u2019s syndrome: a cross-sectional study of 304 Chinese patients. Medicine (Baltimore). 2017;96(50):e9208.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1842_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/ard.2008.094193","volume":"69","author":"L Mouthon","year":"2010","unstructured":"Mouthon L, Mestre-Stanislas C, Berezne A, Rannou F, Guilpain P, Revel M, Pagnoux C, Guillevin L, Fermanian J, Poiraudeau S. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis. 2010;69(1):214\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1842_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/rheumatology\/kex410","volume":"57","author":"S Peytrignet","year":"2018","unstructured":"Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirjak L, Distler JHW, et al. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford). 2018;57(2):370\u201381.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1842_CR45","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3899\/jrheum.110826","volume":"39","author":"MA Omair","year":"2012","unstructured":"Omair MA, Lee P. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis. J Rheumatol. 2012;39(5):992\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"1842_CR46","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/rheumatology\/keq296","volume":"50","author":"V Bodukam","year":"2011","unstructured":"Bodukam V, Hays RD, Maranian P, Furst DE, Seibold JR, Impens A, Mayes MD, Clements PJ, Khanna D. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology (Oxford). 2011;50(2):330\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"6 Suppl 86","key":"1842_CR47","first-page":"S-15-20","volume":"32","author":"S Maddali-Bongi","year":"2014","unstructured":"Maddali-Bongi S, Del Rosso A, Mikhaylova S, Francini B, Branchi A, Baccini M, Matucci-Cerinic M. Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-15-20.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1842_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","volume":"57","author":"VK Jaeger","year":"2018","unstructured":"Jaeger VK, Distler O, Maurer B, Czirjak L, Lorand V, Valentini G, Vettori S, Del Galdo F, Abignano G, Denton C, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57(3):441\u201350.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1842-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1842-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1842-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:18:16Z","timestamp":1581707896000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1842-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1842-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review boards and ethics committees at Seoul National University Hospital. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"61"}}